Interchange Capital Partners, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Interchange Capital Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$0.28 - $1.16 $6,741 - $27,930	24,078 Added 14.5%	190,118 $62,000
Q1 2024 May 08, 2024	BUY	$1.06 - $1.67 $41,544 - $65,452	39,193 Added 30.9%	166,040 $192,000
Q4 2023 Jan 09, 2024	BUY	$1.26 - $1.79 $23,248 - $33,027	18,451 Added 17.02%	126,847 $214,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $21,467 - $33,868	13,334 Added 14.03%	108,396 $196,000
Q2 2023 Aug 08, 2023	BUY	$1.14 - $1.95 $70,967 - $121,391	62,252 Added 189.73%	95,062 $176,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $8,606 - $15,706	7,172 Added 27.97%	32,810 $43,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $30,389 - $65,626	-18,644 Reduced 42.1%	25,638 $43,000
Q3 2022 Nov 07, 2022	BUY	$0.73 - $3.74 $982 - $5,034	1,346 Added 3.13%	44,282 $138,000
Q2 2022 Aug 05, 2022	BUY	$2.2 - $4.2 $22,864 - $43,650	10,393 Added 31.94%	42,936 $102,000
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $92,096 - $282,798	32,543 New	32,543 $131,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $8.15B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Interchange Capital Partners, LLC with notifications on news.